Keyphrases
Autoreactive T Cells
50%
Breast Cancer Patients
50%
Cancer Patients
25%
Cancer Vaccine
25%
CD4+
25%
CD8+
25%
Cell-based
25%
Clinical Development
25%
Clinical Investigation
25%
Dendritic Cells
100%
Enzyme-linked Immunosorbent Spot
25%
Healthy Donors
25%
Immune Therapy
25%
In Cancer
25%
Interleukin-10
25%
Interleukin-2
25%
P53 mRNA
100%
Peripheral Blood
50%
Peripheral Blood Mononuclear Cells
25%
Primary Breast Cancer
100%
Primary Diagnosis
25%
Specific T Cells
25%
T Cell Response
50%
T-cell Reactivity
25%
Tumor
75%
Tumor Antigen
50%
Tumor Expression
50%
Tumor Protein p53 (TP53)
100%
Medicine and Dentistry
Breast Cancer
100%
CD8 Antigen
7%
Dendritic Cell
100%
Immunotherapy
7%
Interleukin 10
7%
Interleukin 2
7%
Malignant Neoplasm
7%
Messenger RNA
100%
Neoplasm
38%
Peripheral Blood Mononuclear Cell
7%
Protein P53
100%
Secretion (Process)
15%
T Cell
30%
T-Cell Response
15%
Tumor Antigen
15%
Tumor Vaccine
7%
Biochemistry, Genetics and Molecular Biology
Anticancer
7%
CD4
7%
CD8
7%
Dendritic Cell
100%
Enzyme
7%
Immunity
7%
Interleukin 10
7%
Interleukin 2
7%
Messenger RNA
100%
P53
100%
Peripheral Blood Mononuclear Cell
7%
Secretion (Process)
15%
T Cell
46%
Tumor Antigen
15%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
CD8 Antigen
7%
Immunotherapy
7%
Interleukin 10
7%
Interleukin 2
7%
Malignant Neoplasm
7%
Messenger RNA
100%
Neoplasm
38%
Protein P53
100%
Tumor Antigen
15%
Tumor Vaccine
7%
Immunology and Microbiology
CD4
7%
CD8
7%
Dendritic Cell
100%
Immunotherapy
7%
Interleukin 10
7%
Interleukin 2
7%
P53
100%
Peripheral Blood Mononuclear Cell
7%
Secretion (Process)
15%
T Cell
46%
Tumor Antigen
15%
Tumor Vaccine
7%